Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant.
Iqbal R, Yaqub M, Bektas HO, Oprea-Lager DE, de Vries EGE, Glaudemans AWJM, Aftimos P, Gebhart G, Beelen AP, Schuit RC, Windhorst AD, Boellaard R, Menke-van der Houven van Oordt CW. Iqbal R, et al. Among authors: aftimos p. Clin Cancer Res. 2023 Jun 1;29(11):2075-2084. doi: 10.1158/1078-0432.CCR-22-2720. Clin Cancer Res. 2023. PMID: 36735488
Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer.
Agostinetto E, Jacobs F, Debien V, De Caluwé A, Pop CF, Catteau X, Aftimos P, de Azambuja E, Buisseret L. Agostinetto E, et al. Among authors: aftimos p. Cancers (Basel). 2022 Nov 7;14(21):5467. doi: 10.3390/cancers14215467. Cancers (Basel). 2022. PMID: 36358886 Free PMC article. Review.
Liquid biopsy accelerates precision medicine.
Amato O, Aftimos P, Ignatiadis M. Amato O, et al. Among authors: aftimos p. Ann Oncol. 2023 Apr;34(4):333-335. doi: 10.1016/j.annonc.2023.02.004. Epub 2023 Feb 16. Ann Oncol. 2023. PMID: 36804455 Free article. No abstract available.
Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysis.
Martins-Branco D, Nader-Marta G, Molinelli C, Ameye L, Paesmans M, Ignatiadis M, Aftimos P, Salgado R, de Azambuja E. Martins-Branco D, et al. Among authors: aftimos p. Eur J Cancer. 2023 Nov;194:113358. doi: 10.1016/j.ejca.2023.113358. Epub 2023 Sep 22. Eur J Cancer. 2023. PMID: 37857118
Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: a rationale to combine targeted drugs based on protein expression inhibition profiles.
Aftimos PG, Wiedig M, Langouo Fontsa M, Awada A, Ghanem G, Journe F. Aftimos PG, et al. Int J Oncol. 2013 Sep;43(3):919-26. doi: 10.3892/ijo.2013.2008. Epub 2013 Jul 8. Int J Oncol. 2013. Retraction in: Int J Oncol. 2025 Jan;66(1):1. doi: 10.3892/ijo.2024.5707 PMID: 23835698 Retracted.
102 results